Related Experiment Video
Updated: Jul 16, 2026

Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery
Published on: November 14, 2018
Comparison of Discharge Readiness in Pediatric Patients: Oral Versus Intranasal Preoperative Midazolam Administration
Mohammad Naem1, Jobayer Hossain2, Janna Hamideh1
1University of Central Florida College of Medicine, Orlando, Florida, USA.
Insights
Age, not the route of midazolam administration, impacts pediatric recovery time after tympanostomy. This study found age is the key factor influencing post-anesthesia care unit (PACU) length of stay, not oral versus intranasal midazolam.
Area of Science:
- Pediatric Anesthesiology
- Pharmacology
- Clinical Outcomes Research
Background:
- Midazolam is frequently used orally or intranasally for preoperative anxiety in pediatric tympanostomy procedures.
- Existing research suggests route-dependent recovery differences, but the impact on post-anesthesia care unit (PACU) length of stay is not well-established.
Purpose of the Study:
- To investigate whether the route of midazolam administration (oral vs. intranasal) influences PACU length of stay in pediatric patients undergoing tympanostomy.
- To identify independent predictors of PACU length of stay in this patient population.
Main Methods:
- Retrospective chart review of 463 pediatric patients (6 months to 10 years) undergoing tympanostomy.
- Patients received either oral (0.5 mg/kg) or intranasal (0.2 mg/kg) midazolam.
- PACU length of stay analyzed using age-adjusted ANCOVA, with logistic regression for predictor evaluation.
Main Results:
- Unadjusted analysis showed intranasal midazolam associated with shorter PACU stay (39.7 vs. 42.9 min).
- Patients receiving intranasal midazolam were significantly younger (31.5 vs. 37.8 months).
- After age adjustment, age was the sole predictor of PACU length of stay; route association became non-significant (p=0.15).
Conclusions:
- Pediatric patient age, not the midazolam administration route, is the primary determinant of PACU discharge readiness after tympanostomy.
- Observed recovery differences between oral and intranasal midazolam may be due to age-related confounding.
- Further prospective, age-stratified research is recommended to refine pediatric sedation guidelines.
Background:
Midazolam is commonly administered orally or intranasally to reduce preoperative anxiety in children undergoing tympanostomy. Prior studies suggest differences in recovery exist between the two routes, but their impact on post-anesthesia care unit (PACU) length of stay remains unclear.
Methods:
We conducted a retrospective chart review of pediatric patients aged 6 months to 10 years undergoing tympanostomy at Nemours Children's Hospital, Central Florida, between November 2023 and November 2024. Patients were grouped by midazolam route (intranasal 0.2 mg/kg IV formulation vs. oral 0.5 mg/kg syrup). The primary outcome was PACU length of stay, defined as time from PACU arrival to discharge based on standard hospital criteria. Predictors of administration route were evaluated using univariate logistic regression, and PACU length of stay was analyzed using age-adjusted ANCOVA with backward stepwise variable selection.
Results:
A total of 463 patients were included: 322 received oral midazolam and 141 received intranasal midazolam. In unadjusted analysis, intranasal midazolam was associated with a shorter PACU stay (mean 39.7 vs. 42.9 min, p = 0.02). However, patients receiving intranasal midazolam were significantly younger (31.5 vs. 37.8 months, p < 0.001). After adjustment for age, age emerged as the only independent predictor of PACU length of stay, and the association between administration route and PACU duration was attenuated and no longer significant (p = 0.15).
Conclusions:
Age, rather than route of midazolam administration, primarily explained differences in PACU discharge readiness among children undergoing tympanostomy. Previously reported differences in recovery time between oral and intranasal midazolam may reflect age-related confounding rather than a true effect of route. Future prospective, age-stratified studies are needed to clarify this relationship and refine pediatric sedation practices.
Related Concept Videos
Parenteral Anesthetics: Overview
Drug Delivery: Enteral Route
Drugs in...
Inhalational Anesthetics: Overview
Drug Dosing: Infants and Children
Stages of General Anesthesia
Suctioning the Nasopharyngeal Airway
Equipment Required